nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP3A4—type 2 diabetes mellitus	0.222	1	CbGaD
Trametinib—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0586	0.13	CbGbCtD
Trametinib—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0469	0.104	CbGbCtD
Trametinib—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0424	0.0941	CbGbCtD
Trametinib—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0391	0.0868	CbGbCtD
Trametinib—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0378	0.0839	CbGbCtD
Trametinib—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0308	0.0684	CbGbCtD
Trametinib—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0267	0.0592	CbGbCtD
Trametinib—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0238	0.0528	CbGbCtD
Trametinib—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0218	0.0483	CbGbCtD
Trametinib—CYP2C8—Losartan—type 2 diabetes mellitus	0.0199	0.044	CbGbCtD
Trametinib—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.019	0.0422	CbGbCtD
Trametinib—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0172	0.0382	CbGbCtD
Trametinib—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.013	0.0289	CbGbCtD
Trametinib—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0125	0.0277	CbGbCtD
Trametinib—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0125	0.0277	CbGbCtD
Trametinib—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0118	0.0262	CbGbCtD
Trametinib—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0088	0.0195	CbGbCtD
Trametinib—CYP3A4—Losartan—type 2 diabetes mellitus	0.00805	0.0179	CbGbCtD
Trametinib—MAP2K2—islet of Langerhans—type 2 diabetes mellitus	0.00179	0.119	CbGeAlD
Trametinib—MAP2K1—cardiovascular system—type 2 diabetes mellitus	0.00147	0.0974	CbGeAlD
Trametinib—MAP2K1—kidney—type 2 diabetes mellitus	0.00144	0.0953	CbGeAlD
Trametinib—MAP2K1—adipose tissue—type 2 diabetes mellitus	0.0013	0.0859	CbGeAlD
Trametinib—MAP2K2—cardiovascular system—type 2 diabetes mellitus	0.00129	0.0857	CbGeAlD
Trametinib—MAP2K2—kidney—type 2 diabetes mellitus	0.00127	0.0839	CbGeAlD
Trametinib—MAP2K2—pancreas—type 2 diabetes mellitus	0.00126	0.0833	CbGeAlD
Trametinib—MAP2K2—cortex of kidney—type 2 diabetes mellitus	0.00123	0.0817	CbGeAlD
Trametinib—MAP2K2—adipose tissue—type 2 diabetes mellitus	0.00114	0.0756	CbGeAlD
Trametinib—MAP2K1—liver—type 2 diabetes mellitus	0.00091	0.0602	CbGeAlD
Trametinib—MAP2K2—liver—type 2 diabetes mellitus	0.000801	0.053	CbGeAlD
Trametinib—CYP2C8—kidney—type 2 diabetes mellitus	0.000439	0.029	CbGeAlD
Trametinib—CYP3A4—kidney—type 2 diabetes mellitus	0.000297	0.0197	CbGeAlD
Trametinib—CYP2C8—liver—type 2 diabetes mellitus	0.000277	0.0184	CbGeAlD
Trametinib—CYP3A4—liver—type 2 diabetes mellitus	0.000188	0.0124	CbGeAlD
Trametinib—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000149	0.0009	CcSEcCtD
Trametinib—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000149	0.0009	CcSEcCtD
Trametinib—Vision blurred—Metformin—type 2 diabetes mellitus	0.000149	0.000899	CcSEcCtD
Trametinib—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000149	0.000899	CcSEcCtD
Trametinib—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000149	0.000896	CcSEcCtD
Trametinib—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000149	0.000896	CcSEcCtD
Trametinib—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000148	0.000895	CcSEcCtD
Trametinib—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000148	0.000892	CcSEcCtD
Trametinib—Myalgia—Valsartan—type 2 diabetes mellitus	0.000148	0.000892	CcSEcCtD
Trametinib—Dizziness—Glipizide—type 2 diabetes mellitus	0.000148	0.000891	CcSEcCtD
Trametinib—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000147	0.000889	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000147	0.000886	CcSEcCtD
Trametinib—Angiopathy—Losartan—type 2 diabetes mellitus	0.000146	0.000883	CcSEcCtD
Trametinib—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000146	0.000883	CcSEcCtD
Trametinib—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000146	0.000882	CcSEcCtD
Trametinib—Myalgia—Orlistat—type 2 diabetes mellitus	0.000146	0.000881	CcSEcCtD
Trametinib—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000145	0.000877	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000145	0.000875	CcSEcCtD
Trametinib—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000145	0.000872	CcSEcCtD
Trametinib—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000144	0.00087	CcSEcCtD
Trametinib—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000143	0.000866	CcSEcCtD
Trametinib—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000143	0.000862	CcSEcCtD
Trametinib—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000143	0.00086	CcSEcCtD
Trametinib—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000142	0.000857	CcSEcCtD
Trametinib—Vomiting—Glipizide—type 2 diabetes mellitus	0.000142	0.000856	CcSEcCtD
Trametinib—Oedema—Valsartan—type 2 diabetes mellitus	0.000142	0.000855	CcSEcCtD
Trametinib—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000141	0.000853	CcSEcCtD
Trametinib—Infection—Valsartan—type 2 diabetes mellitus	0.000141	0.00085	CcSEcCtD
Trametinib—Rash—Glipizide—type 2 diabetes mellitus	0.000141	0.000849	CcSEcCtD
Trametinib—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000141	0.000849	CcSEcCtD
Trametinib—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000141	0.000848	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000141	0.000848	CcSEcCtD
Trametinib—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00014	0.000848	CcSEcCtD
Trametinib—Erythema—Losartan—type 2 diabetes mellitus	0.00014	0.000847	CcSEcCtD
Trametinib—Oedema—Orlistat—type 2 diabetes mellitus	0.00014	0.000845	CcSEcCtD
Trametinib—Headache—Glipizide—type 2 diabetes mellitus	0.00014	0.000844	CcSEcCtD
Trametinib—Insomnia—Gliclazide—type 2 diabetes mellitus	0.00014	0.000842	CcSEcCtD
Trametinib—Infection—Orlistat—type 2 diabetes mellitus	0.000139	0.000839	CcSEcCtD
Trametinib—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000139	0.000839	CcSEcCtD
Trametinib—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000139	0.000837	CcSEcCtD
Trametinib—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000138	0.000832	CcSEcCtD
Trametinib—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000138	0.000831	CcSEcCtD
Trametinib—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000138	0.000831	CcSEcCtD
Trametinib—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000138	0.00083	CcSEcCtD
Trametinib—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000137	0.000829	CcSEcCtD
Trametinib—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000137	0.000829	CcSEcCtD
Trametinib—Hypertension—Metformin—type 2 diabetes mellitus	0.000137	0.000824	CcSEcCtD
Trametinib—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000136	0.000822	CcSEcCtD
Trametinib—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000136	0.000821	CcSEcCtD
Trametinib—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000136	0.00082	CcSEcCtD
Trametinib—Back pain—Losartan—type 2 diabetes mellitus	0.000136	0.00082	CcSEcCtD
Trametinib—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000136	0.000819	CcSEcCtD
Trametinib—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000135	0.000817	CcSEcCtD
Trametinib—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000135	0.000815	CcSEcCtD
Trametinib—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000135	0.000814	CcSEcCtD
Trametinib—Myalgia—Metformin—type 2 diabetes mellitus	0.000135	0.000812	CcSEcCtD
Trametinib—Headache—Pioglitazone—type 2 diabetes mellitus	0.000134	0.000808	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000134	0.000807	CcSEcCtD
Trametinib—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000134	0.000806	CcSEcCtD
Trametinib—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000133	0.000804	CcSEcCtD
Trametinib—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000133	0.000802	CcSEcCtD
Trametinib—Nausea—Glipizide—type 2 diabetes mellitus	0.000133	0.0008	CcSEcCtD
Trametinib—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000132	0.000799	CcSEcCtD
Trametinib—Vision blurred—Losartan—type 2 diabetes mellitus	0.000132	0.000799	CcSEcCtD
Trametinib—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000132	0.000797	CcSEcCtD
Trametinib—Constipation—Gliclazide—type 2 diabetes mellitus	0.000132	0.000796	CcSEcCtD
Trametinib—Rash—Glimepiride—type 2 diabetes mellitus	0.000131	0.000793	CcSEcCtD
Trametinib—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000131	0.000792	CcSEcCtD
Trametinib—Rash—Sitagliptin—type 2 diabetes mellitus	0.000131	0.00079	CcSEcCtD
Trametinib—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000131	0.000789	CcSEcCtD
Trametinib—Headache—Glimepiride—type 2 diabetes mellitus	0.00013	0.000787	CcSEcCtD
Trametinib—Cough—Irbesartan—type 2 diabetes mellitus	0.00013	0.000786	CcSEcCtD
Trametinib—Headache—Sitagliptin—type 2 diabetes mellitus	0.00013	0.000785	CcSEcCtD
Trametinib—Anaemia—Losartan—type 2 diabetes mellitus	0.00013	0.000783	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000129	0.000779	CcSEcCtD
Trametinib—Oedema—Metformin—type 2 diabetes mellitus	0.000129	0.000779	CcSEcCtD
Trametinib—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000129	0.000777	CcSEcCtD
Trametinib—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000129	0.000776	CcSEcCtD
Trametinib—Infection—Metformin—type 2 diabetes mellitus	0.000128	0.000774	CcSEcCtD
Trametinib—Insomnia—Valsartan—type 2 diabetes mellitus	0.000128	0.000773	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000128	0.00077	CcSEcCtD
Trametinib—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000127	0.000767	CcSEcCtD
Trametinib—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000127	0.000767	CcSEcCtD
Trametinib—Insomnia—Orlistat—type 2 diabetes mellitus	0.000127	0.000764	CcSEcCtD
Trametinib—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000127	0.000764	CcSEcCtD
Trametinib—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000126	0.000762	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000126	0.000761	CcSEcCtD
Trametinib—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000126	0.000761	CcSEcCtD
Trametinib—Leukopenia—Losartan—type 2 diabetes mellitus	0.000126	0.000759	CcSEcCtD
Trametinib—Skin disorder—Metformin—type 2 diabetes mellitus	0.000125	0.000756	CcSEcCtD
Trametinib—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000125	0.000753	CcSEcCtD
Trametinib—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000125	0.000752	CcSEcCtD
Trametinib—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000124	0.00075	CcSEcCtD
Trametinib—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000124	0.00075	CcSEcCtD
Trametinib—Nausea—Glimepiride—type 2 diabetes mellitus	0.000124	0.000747	CcSEcCtD
Trametinib—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000124	0.000746	CcSEcCtD
Trametinib—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000123	0.000744	CcSEcCtD
Trametinib—Asthenia—Glyburide—type 2 diabetes mellitus	0.000123	0.000744	CcSEcCtD
Trametinib—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000123	0.000743	CcSEcCtD
Trametinib—Cough—Losartan—type 2 diabetes mellitus	0.000123	0.000739	CcSEcCtD
Trametinib—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000122	0.000738	CcSEcCtD
Trametinib—Fatigue—Valsartan—type 2 diabetes mellitus	0.000122	0.000737	CcSEcCtD
Trametinib—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000122	0.000736	CcSEcCtD
Trametinib—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000122	0.000736	CcSEcCtD
Trametinib—Oedema—Irbesartan—type 2 diabetes mellitus	0.000122	0.000735	CcSEcCtD
Trametinib—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000122	0.000735	CcSEcCtD
Trametinib—Pruritus—Glyburide—type 2 diabetes mellitus	0.000122	0.000733	CcSEcCtD
Trametinib—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000121	0.000731	CcSEcCtD
Trametinib—Constipation—Valsartan—type 2 diabetes mellitus	0.000121	0.000731	CcSEcCtD
Trametinib—Infection—Irbesartan—type 2 diabetes mellitus	0.000121	0.00073	CcSEcCtD
Trametinib—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000121	0.00073	CcSEcCtD
Trametinib—Fatigue—Orlistat—type 2 diabetes mellitus	0.000121	0.000729	CcSEcCtD
Trametinib—Erythema—Ramipril—type 2 diabetes mellitus	0.00012	0.000727	CcSEcCtD
Trametinib—Malnutrition—Ramipril—type 2 diabetes mellitus	0.00012	0.000727	CcSEcCtD
Trametinib—Myalgia—Losartan—type 2 diabetes mellitus	0.00012	0.000721	CcSEcCtD
Trametinib—Arthralgia—Losartan—type 2 diabetes mellitus	0.00012	0.000721	CcSEcCtD
Trametinib—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000119	0.000721	CcSEcCtD
Trametinib—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000119	0.000721	CcSEcCtD
Trametinib—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000119	0.00072	CcSEcCtD
Trametinib—Rash—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000715	CcSEcCtD
Trametinib—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000714	CcSEcCtD
Trametinib—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000118	0.000714	CcSEcCtD
Trametinib—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000118	0.000712	CcSEcCtD
Trametinib—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000118	0.00071	CcSEcCtD
Trametinib—Headache—Bromocriptine—type 2 diabetes mellitus	0.000118	0.00071	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000118	0.00071	CcSEcCtD
Trametinib—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000118	0.000709	CcSEcCtD
Trametinib—Dry mouth—Losartan—type 2 diabetes mellitus	0.000117	0.000706	CcSEcCtD
Trametinib—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000116	0.000699	CcSEcCtD
Trametinib—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000116	0.000699	CcSEcCtD
Trametinib—Oedema—Losartan—type 2 diabetes mellitus	0.000115	0.000692	CcSEcCtD
Trametinib—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000115	0.000691	CcSEcCtD
Trametinib—Infection—Losartan—type 2 diabetes mellitus	0.000114	0.000687	CcSEcCtD
Trametinib—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000112	0.000678	CcSEcCtD
Trametinib—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000112	0.000677	CcSEcCtD
Trametinib—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000112	0.000677	CcSEcCtD
Trametinib—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000112	0.000676	CcSEcCtD
Trametinib—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000112	0.000674	CcSEcCtD
Trametinib—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000111	0.000672	CcSEcCtD
Trametinib—Fatigue—Metformin—type 2 diabetes mellitus	0.000111	0.000671	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000111	0.00067	CcSEcCtD
Trametinib—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000111	0.000669	CcSEcCtD
Trametinib—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000111	0.000668	CcSEcCtD
Trametinib—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000111	0.000668	CcSEcCtD
Trametinib—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000111	0.000668	CcSEcCtD
Trametinib—Constipation—Metformin—type 2 diabetes mellitus	0.00011	0.000666	CcSEcCtD
Trametinib—Vomiting—Glyburide—type 2 diabetes mellitus	0.000109	0.000659	CcSEcCtD
Trametinib—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000109	0.000659	CcSEcCtD
Trametinib—Rash—Glyburide—type 2 diabetes mellitus	0.000108	0.000654	CcSEcCtD
Trametinib—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000108	0.000653	CcSEcCtD
Trametinib—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000108	0.00065	CcSEcCtD
Trametinib—Headache—Glyburide—type 2 diabetes mellitus	0.000108	0.000649	CcSEcCtD
Trametinib—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000106	0.000639	CcSEcCtD
Trametinib—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000106	0.000637	CcSEcCtD
Trametinib—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000106	0.000637	CcSEcCtD
Trametinib—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000105	0.000634	CcSEcCtD
Trametinib—Cough—Ramipril—type 2 diabetes mellitus	0.000105	0.000634	CcSEcCtD
Trametinib—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000105	0.000634	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000104	0.00063	CcSEcCtD
Trametinib—Constipation—Irbesartan—type 2 diabetes mellitus	0.000104	0.000628	CcSEcCtD
Trametinib—Insomnia—Losartan—type 2 diabetes mellitus	0.000104	0.000626	CcSEcCtD
Trametinib—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000103	0.000619	CcSEcCtD
Trametinib—Myalgia—Ramipril—type 2 diabetes mellitus	0.000103	0.000619	CcSEcCtD
Trametinib—Nausea—Glyburide—type 2 diabetes mellitus	0.000102	0.000616	CcSEcCtD
Trametinib—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000102	0.000616	CcSEcCtD
Trametinib—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000102	0.000616	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000102	0.000614	CcSEcCtD
Trametinib—Asthenia—Valsartan—type 2 diabetes mellitus	0.000102	0.000614	CcSEcCtD
Trametinib—Asthenia—Orlistat—type 2 diabetes mellitus	0.0001	0.000606	CcSEcCtD
Trametinib—Pruritus—Valsartan—type 2 diabetes mellitus	0.0001	0.000605	CcSEcCtD
Trametinib—Dry mouth—Ramipril—type 2 diabetes mellitus	0.0001	0.000605	CcSEcCtD
Trametinib—Decreased appetite—Losartan—type 2 diabetes mellitus	9.96e-05	0.000601	CcSEcCtD
Trametinib—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.96e-05	0.000601	CcSEcCtD
Trametinib—Pruritus—Orlistat—type 2 diabetes mellitus	9.91e-05	0.000598	CcSEcCtD
Trametinib—Fatigue—Losartan—type 2 diabetes mellitus	9.88e-05	0.000596	CcSEcCtD
Trametinib—Oedema—Ramipril—type 2 diabetes mellitus	9.83e-05	0.000593	CcSEcCtD
Trametinib—Vomiting—Gliclazide—type 2 diabetes mellitus	9.81e-05	0.000592	CcSEcCtD
Trametinib—Constipation—Losartan—type 2 diabetes mellitus	9.8e-05	0.000591	CcSEcCtD
Trametinib—Rash—Gliclazide—type 2 diabetes mellitus	9.73e-05	0.000587	CcSEcCtD
Trametinib—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.72e-05	0.000586	CcSEcCtD
Trametinib—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.7e-05	0.000585	CcSEcCtD
Trametinib—Headache—Gliclazide—type 2 diabetes mellitus	9.66e-05	0.000583	CcSEcCtD
Trametinib—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.64e-05	0.000582	CcSEcCtD
Trametinib—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.63e-05	0.000581	CcSEcCtD
Trametinib—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.63e-05	0.000581	CcSEcCtD
Trametinib—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.62e-05	0.000581	CcSEcCtD
Trametinib—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.58e-05	0.000578	CcSEcCtD
Trametinib—Skin disorder—Ramipril—type 2 diabetes mellitus	9.55e-05	0.000576	CcSEcCtD
Trametinib—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.5e-05	0.000573	CcSEcCtD
Trametinib—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.37e-05	0.000566	CcSEcCtD
Trametinib—Dizziness—Valsartan—type 2 diabetes mellitus	9.37e-05	0.000566	CcSEcCtD
Trametinib—Dizziness—Orlistat—type 2 diabetes mellitus	9.26e-05	0.000559	CcSEcCtD
Trametinib—Asthenia—Metformin—type 2 diabetes mellitus	9.26e-05	0.000559	CcSEcCtD
Trametinib—Nausea—Gliclazide—type 2 diabetes mellitus	9.16e-05	0.000553	CcSEcCtD
Trametinib—Pruritus—Metformin—type 2 diabetes mellitus	9.13e-05	0.000551	CcSEcCtD
Trametinib—Abdominal pain—Losartan—type 2 diabetes mellitus	9.06e-05	0.000547	CcSEcCtD
Trametinib—Body temperature increased—Losartan—type 2 diabetes mellitus	9.06e-05	0.000547	CcSEcCtD
Trametinib—Vomiting—Valsartan—type 2 diabetes mellitus	9.01e-05	0.000544	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.95e-05	0.00054	CcSEcCtD
Trametinib—Rash—Valsartan—type 2 diabetes mellitus	8.94e-05	0.000539	CcSEcCtD
Trametinib—Dermatitis—Valsartan—type 2 diabetes mellitus	8.93e-05	0.000539	CcSEcCtD
Trametinib—Vomiting—Orlistat—type 2 diabetes mellitus	8.9e-05	0.000537	CcSEcCtD
Trametinib—Insomnia—Ramipril—type 2 diabetes mellitus	8.89e-05	0.000536	CcSEcCtD
Trametinib—Headache—Valsartan—type 2 diabetes mellitus	8.88e-05	0.000536	CcSEcCtD
Trametinib—Diarrhoea—Metformin—type 2 diabetes mellitus	8.83e-05	0.000533	CcSEcCtD
Trametinib—Rash—Orlistat—type 2 diabetes mellitus	8.83e-05	0.000533	CcSEcCtD
Trametinib—Dermatitis—Orlistat—type 2 diabetes mellitus	8.82e-05	0.000532	CcSEcCtD
Trametinib—Headache—Orlistat—type 2 diabetes mellitus	8.77e-05	0.000529	CcSEcCtD
Trametinib—Asthenia—Irbesartan—type 2 diabetes mellitus	8.74e-05	0.000527	CcSEcCtD
Trametinib—Pruritus—Irbesartan—type 2 diabetes mellitus	8.62e-05	0.00052	CcSEcCtD
Trametinib—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000516	CcSEcCtD
Trametinib—Dizziness—Metformin—type 2 diabetes mellitus	8.53e-05	0.000515	CcSEcCtD
Trametinib—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.49e-05	0.000512	CcSEcCtD
Trametinib—Fatigue—Ramipril—type 2 diabetes mellitus	8.47e-05	0.000511	CcSEcCtD
Trametinib—Nausea—Valsartan—type 2 diabetes mellitus	8.42e-05	0.000508	CcSEcCtD
Trametinib—Constipation—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000507	CcSEcCtD
Trametinib—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.33e-05	0.000503	CcSEcCtD
Trametinib—Nausea—Orlistat—type 2 diabetes mellitus	8.32e-05	0.000502	CcSEcCtD
Trametinib—Asthenia—Losartan—type 2 diabetes mellitus	8.22e-05	0.000496	CcSEcCtD
Trametinib—Vomiting—Metformin—type 2 diabetes mellitus	8.21e-05	0.000495	CcSEcCtD
Trametinib—Rash—Metformin—type 2 diabetes mellitus	8.14e-05	0.000491	CcSEcCtD
Trametinib—Dermatitis—Metformin—type 2 diabetes mellitus	8.13e-05	0.000491	CcSEcCtD
Trametinib—Pruritus—Losartan—type 2 diabetes mellitus	8.11e-05	0.000489	CcSEcCtD
Trametinib—Headache—Metformin—type 2 diabetes mellitus	8.09e-05	0.000488	CcSEcCtD
Trametinib—Dizziness—Irbesartan—type 2 diabetes mellitus	8.05e-05	0.000486	CcSEcCtD
Trametinib—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.04e-05	0.000485	CcSEcCtD
Trametinib—Diarrhoea—Losartan—type 2 diabetes mellitus	7.84e-05	0.000473	CcSEcCtD
Trametinib—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.77e-05	0.000469	CcSEcCtD
Trametinib—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.77e-05	0.000469	CcSEcCtD
Trametinib—Vomiting—Irbesartan—type 2 diabetes mellitus	7.74e-05	0.000467	CcSEcCtD
Trametinib—Rash—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.000463	CcSEcCtD
Trametinib—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.67e-05	0.000463	CcSEcCtD
Trametinib—Nausea—Metformin—type 2 diabetes mellitus	7.67e-05	0.000463	CcSEcCtD
Trametinib—Headache—Irbesartan—type 2 diabetes mellitus	7.63e-05	0.00046	CcSEcCtD
Trametinib—Dizziness—Losartan—type 2 diabetes mellitus	7.58e-05	0.000457	CcSEcCtD
Trametinib—Vomiting—Losartan—type 2 diabetes mellitus	7.29e-05	0.00044	CcSEcCtD
Trametinib—Nausea—Irbesartan—type 2 diabetes mellitus	7.23e-05	0.000437	CcSEcCtD
Trametinib—Rash—Losartan—type 2 diabetes mellitus	7.23e-05	0.000436	CcSEcCtD
Trametinib—Dermatitis—Losartan—type 2 diabetes mellitus	7.22e-05	0.000436	CcSEcCtD
Trametinib—Headache—Losartan—type 2 diabetes mellitus	7.18e-05	0.000433	CcSEcCtD
Trametinib—Asthenia—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000425	CcSEcCtD
Trametinib—Pruritus—Ramipril—type 2 diabetes mellitus	6.95e-05	0.00042	CcSEcCtD
Trametinib—Nausea—Losartan—type 2 diabetes mellitus	6.81e-05	0.000411	CcSEcCtD
Trametinib—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.72e-05	0.000406	CcSEcCtD
Trametinib—Dizziness—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000392	CcSEcCtD
Trametinib—Vomiting—Ramipril—type 2 diabetes mellitus	6.25e-05	0.000377	CcSEcCtD
Trametinib—Rash—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000374	CcSEcCtD
Trametinib—Dermatitis—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000374	CcSEcCtD
Trametinib—Headache—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000372	CcSEcCtD
Trametinib—Nausea—Ramipril—type 2 diabetes mellitus	5.84e-05	0.000352	CcSEcCtD
Trametinib—MAP2K1—Immune System—CASP8—type 2 diabetes mellitus	8.62e-06	5.89e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AVP—type 2 diabetes mellitus	8.57e-06	5.86e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.57e-06	5.86e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—EGFR—type 2 diabetes mellitus	8.55e-06	5.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.54e-06	5.83e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.5e-06	5.81e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	8.47e-06	5.79e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	8.47e-06	5.79e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—AKT2—type 2 diabetes mellitus	8.47e-06	5.79e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—LPL—type 2 diabetes mellitus	8.46e-06	5.78e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IRS1—type 2 diabetes mellitus	8.45e-06	5.77e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.41e-06	5.75e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—AKT2—type 2 diabetes mellitus	8.36e-06	5.71e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOB—type 2 diabetes mellitus	8.29e-06	5.66e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.28e-06	5.66e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.25e-06	5.64e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PIK3R1—type 2 diabetes mellitus	8.21e-06	5.61e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	8.18e-06	5.59e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	8.18e-06	5.59e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	8.18e-06	5.59e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	8.18e-06	5.59e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	8.18e-06	5.59e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	8.17e-06	5.59e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.15e-06	5.57e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—INS—type 2 diabetes mellitus	8.09e-06	5.53e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	8.01e-06	5.47e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	8.01e-06	5.47e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—IL6—type 2 diabetes mellitus	7.96e-06	5.44e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SERPINE1—type 2 diabetes mellitus	7.94e-06	5.43e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.93e-06	5.42e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.92e-06	5.41e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LPL—type 2 diabetes mellitus	7.91e-06	5.41e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—BCL2—type 2 diabetes mellitus	7.91e-06	5.4e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	7.85e-06	5.37e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—AKT2—type 2 diabetes mellitus	7.82e-06	5.34e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.81e-06	5.33e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	7.8e-06	5.33e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	7.8e-06	5.33e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	7.8e-06	5.33e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.79e-06	5.32e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	7.75e-06	5.3e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.75e-06	5.29e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—RELA—type 2 diabetes mellitus	7.73e-06	5.28e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PIK3R1—type 2 diabetes mellitus	7.68e-06	5.25e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	7.62e-06	5.2e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—C3—type 2 diabetes mellitus	7.61e-06	5.2e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS3—type 2 diabetes mellitus	7.58e-06	5.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PIK3R1—type 2 diabetes mellitus	7.58e-06	5.18e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	7.53e-06	5.14e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.48e-06	5.11e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.48e-06	5.11e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—type 2 diabetes mellitus	7.44e-06	5.09e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SERPINE1—type 2 diabetes mellitus	7.43e-06	5.08e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.42e-06	5.07e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—BCL2—type 2 diabetes mellitus	7.4e-06	5.06e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—AKT1—type 2 diabetes mellitus	7.34e-06	5.02e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.29e-06	4.98e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.29e-06	4.98e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.26e-06	4.96e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.24e-06	4.95e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AGT—type 2 diabetes mellitus	7.23e-06	4.94e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—RELA—type 2 diabetes mellitus	7.23e-06	4.94e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—C3—type 2 diabetes mellitus	7.12e-06	4.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.11e-06	4.86e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PIK3R1—type 2 diabetes mellitus	7.09e-06	4.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS3—type 2 diabetes mellitus	7.09e-06	4.85e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOE—type 2 diabetes mellitus	7.09e-06	4.84e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—LEP—type 2 diabetes mellitus	7.09e-06	4.84e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—type 2 diabetes mellitus	7.03e-06	4.8e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.02e-06	4.8e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.01e-06	4.79e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	7e-06	4.78e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	7e-06	4.78e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	7e-06	4.78e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.96e-06	4.75e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.96e-06	4.75e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.96e-06	4.75e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—type 2 diabetes mellitus	6.94e-06	4.74e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	6.87e-06	4.69e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—AKT1—type 2 diabetes mellitus	6.87e-06	4.69e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	6.81e-06	4.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.79e-06	4.64e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.78e-06	4.63e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.77e-06	4.63e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.71e-06	4.59e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.68e-06	4.57e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.67e-06	4.56e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.67e-06	4.56e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	6.66e-06	4.55e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.66e-06	4.55e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LEP—type 2 diabetes mellitus	6.63e-06	4.53e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOE—type 2 diabetes mellitus	6.63e-06	4.53e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—type 2 diabetes mellitus	6.57e-06	4.49e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.56e-06	4.48e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—NFKB1—type 2 diabetes mellitus	6.52e-06	4.46e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—type 2 diabetes mellitus	6.49e-06	4.43e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—AKT1—type 2 diabetes mellitus	6.48e-06	4.43e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.42e-06	4.39e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.42e-06	4.39e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	6.4e-06	4.37e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	6.33e-06	4.33e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	6.33e-06	4.33e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.32e-06	4.32e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.31e-06	4.31e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.25e-06	4.27e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.2e-06	4.24e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.2e-06	4.24e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.2e-06	4.24e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	6.17e-06	4.22e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.14e-06	4.2e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—NFKB1—type 2 diabetes mellitus	6.1e-06	4.17e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—SRC—type 2 diabetes mellitus	6.08e-06	4.15e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	6.07e-06	4.15e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	6.07e-06	4.15e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—AKT1—type 2 diabetes mellitus	6.06e-06	4.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—INS—type 2 diabetes mellitus	6.06e-06	4.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.96e-06	4.07e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.92e-06	4.04e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.86e-06	4e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.85e-06	4e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.83e-06	3.98e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.83e-06	3.98e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—SRC—type 2 diabetes mellitus	5.68e-06	3.88e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—INS—type 2 diabetes mellitus	5.67e-06	3.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SRC—type 2 diabetes mellitus	5.61e-06	3.83e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.57e-06	3.81e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.56e-06	3.8e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.48e-06	3.75e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.48e-06	3.74e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.46e-06	3.73e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.45e-06	3.73e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—EGFR—type 2 diabetes mellitus	5.33e-06	3.64e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.31e-06	3.63e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.31e-06	3.63e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.27e-06	3.6e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.27e-06	3.6e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.27e-06	3.6e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.27e-06	3.6e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SRC—type 2 diabetes mellitus	5.25e-06	3.59e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	5.23e-06	3.57e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.23e-06	3.57e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	5.21e-06	3.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.2e-06	3.56e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	5.14e-06	3.51e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.05e-06	3.45e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TGFB1—type 2 diabetes mellitus	5.01e-06	3.43e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RELA—type 2 diabetes mellitus	5e-06	3.42e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	4.99e-06	3.41e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—EGFR—type 2 diabetes mellitus	4.98e-06	3.4e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.97e-06	3.4e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.97e-06	3.4e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—EGFR—type 2 diabetes mellitus	4.92e-06	3.36e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	4.85e-06	3.32e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	4.76e-06	3.25e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.7e-06	3.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TGFB1—type 2 diabetes mellitus	4.69e-06	3.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.68e-06	3.2e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	4.66e-06	3.19e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	4.65e-06	3.17e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—EGFR—type 2 diabetes mellitus	4.6e-06	3.14e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	4.52e-06	3.09e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.51e-06	3.08e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.48e-06	3.06e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	4.47e-06	3.05e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.39e-06	3e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.3e-06	2.94e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.3e-06	2.94e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	4.29e-06	2.93e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.26e-06	2.91e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.22e-06	2.88e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.22e-06	2.88e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.21e-06	2.88e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	4.21e-06	2.87e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.19e-06	2.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.19e-06	2.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.19e-06	2.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.19e-06	2.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.16e-06	2.84e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.13e-06	2.82e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—type 2 diabetes mellitus	4.09e-06	2.8e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.09e-06	2.79e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	4.07e-06	2.78e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.04e-06	2.76e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	4.01e-06	2.74e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	3.99e-06	2.73e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.99e-06	2.72e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	3.95e-06	2.7e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.94e-06	2.7e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.93e-06	2.68e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.87e-06	2.64e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—type 2 diabetes mellitus	3.83e-06	2.62e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.83e-06	2.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—type 2 diabetes mellitus	3.78e-06	2.58e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—AKT1—type 2 diabetes mellitus	3.78e-06	2.58e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.76e-06	2.57e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.76e-06	2.57e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.76e-06	2.57e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.69e-06	2.52e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.68e-06	2.51e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.65e-06	2.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.58e-06	2.45e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.58e-06	2.44e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—type 2 diabetes mellitus	3.54e-06	2.42e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—AKT1—type 2 diabetes mellitus	3.53e-06	2.41e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.51e-06	2.4e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—AKT1—type 2 diabetes mellitus	3.49e-06	2.38e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3.48e-06	2.38e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.44e-06	2.35e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.44e-06	2.35e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	3.41e-06	2.33e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.4e-06	2.32e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.4e-06	2.32e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.29e-06	2.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—AKT1—type 2 diabetes mellitus	3.26e-06	2.23e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.26e-06	2.23e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.26e-06	2.23e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.22e-06	2.2e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	3.13e-06	2.14e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.99e-06	2.04e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.99e-06	2.04e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.81e-06	1.92e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.81e-06	1.92e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.79e-06	1.91e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.76e-06	1.88e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.73e-06	1.87e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.68e-06	1.83e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.65e-06	1.81e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.6e-06	1.78e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.56e-06	1.75e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.5e-06	1.71e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.49e-06	1.7e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.48e-06	1.69e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.44e-06	1.67e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.43e-06	1.66e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.4e-06	1.64e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.3e-06	1.57e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.28e-06	1.56e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.26e-06	1.54e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.19e-06	1.49e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.15e-06	1.47e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.14e-06	1.46e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.12e-06	1.45e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.87e-06	1.28e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.83e-06	1.25e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.68e-06	1.15e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.6e-06	1.1e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.6e-06	1.1e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.47e-06	1e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.37e-06	9.39e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.38e-07	5.04e-06	CbGpPWpGaD
